Lysophosphatidylcholine: a chemoattractant to human T lymphocytes
- 1 October 1994
- journal article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 286 (8) , 462-465
- https://doi.org/10.1007/bf00371572
Abstract
Various cell stimuli act through activation of phospholipase A2 resulting in the release of arachidonic acid, the precursor of eicosanoids, from the sn-2 position of cell membrane phospholipids. A byproduct of phospholipase A2 activity is the lysophospholipids which have been found to potentiate T-lymphocyte activation. The purpose of the present study was to determine whether the various lysophospholipids modulate the migration of peripheral normal human T lymphocytes in vitro. It was found that lysophosphatidylcholine (lysoPC) induced T-lymphocyte migration in the concentration range 10−7 to 10−4 M with a maximum at 10−6 M (mean chemotactic index, 2.06). The migration was due to chemotaxis rather than chemokinesis. In contrast, lysophosphatidylethanolamine (lysoPE) and lysophosphatidylinositol (lysoPI) did not exhibit chemotactic properties towards T lymphocytes. Further studies showed that the length of the fatty acids in the sn-1 position as well as the presence of double bonds modulated the chemotactic ability. The lysoPC compound with the highest chemotactic activity was lysoPC;1-palmitoyl (C=16∶0). The results demonstrated that lysoPC, a phospholipase A2-generated hydrolysis product of phosphatidylcholine, induced T-lymphocyte chemotaxis in vitro. Because phosphatidylcholine is the major phospholipid in the epidermis, the activation of phospholipase A2 may result in the release of lysoPC in concentrations capable of inducing migration of T lymphocytes into the epidermis.Keywords
This publication has 16 references indexed in Scilit:
- Monohydroxy fatty acids esterified to phospholipids are decreased in lesional psoriatic skinArchives of Dermatological Research, 1993
- Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells.Journal of Clinical Investigation, 1992
- Lysophosphatidylcholine induces mast cell secretion and protein kinase C activationJournal of Allergy and Clinical Immunology, 1991
- Lysophosphatidylcholine as a possible second messenger synergistic to diacylglycerol and calcium ion for T-lymphocyte activationBiochemical and Biophysical Research Communications, 1991
- Analysis of the monocyte chemotactic response to lysophosphatidylcholine: role of lysophospholipase CBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Eicosanoids in skin of patients with atopic dermatitis: Prostaglandin E and leukotriene B are present in biologically active concentrationsJournal of Allergy and Clinical Immunology, 1989
- Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.Proceedings of the National Academy of Sciences, 1988
- Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytesImmunology Today, 1986
- Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczemaBritish Journal of Dermatology, 1985
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983